Peptídeos

A synthetic peptide for use as a blocking control in assays to test for specificity of TRIB2 antibody, catalog no. 70R-2069

A synthetic peptide for use as a blocking control in assays to test for specificity of RXRA antibody, catalog no. 70R-1922

A synthetic peptide for use as a blocking control in assays to test for specificity of Hoxb9 antibody, catalog no. 70R-7888

A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM23 antibody, catalog no. 70R-7942

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF227 antibody, catalog no. 70R-8165

A synthetic peptide for use as a blocking control in assays to test for specificity of Nbr1 antibody, catalog no. 70R-9239

ß-Alanyl-L-Histidine is a dipeptide that is naturally occurring in the human body and is involved in many biochemical processes. It is a precursor of carnosine, which can be found in muscle and brain tissue. Carnosine has been shown to have antioxidant properties and has been used as a supplement for those who are at risk of developing diabetes. Carnosine supplementation has also been shown to improve exercise performance by increasing muscle strength and improving the function of muscle cells. ß-Alanyl-L-Histidine may also have metal chelate properties due to its ability to bind metals such as iron and copper.

A synthetic peptide for use as a blocking control in assays to test for specificity of EVX2 antibody, catalog no. 70R-8467

A synthetic peptide for use as a blocking control in assays to test for specificity of GNAI3 antibody, catalog no. 70R-9627

A synthetic peptide for use as a blocking control in assays to test for specificity of XRCC3 antibody, catalog no. 70R-10279

A synthetic peptide for use as a blocking control in assays to test for specificity of UBD antibody, catalog no. 70R-5744

A synthetic peptide for use as a blocking control in assays to test for specificity of VMD2L2 antibody, catalog no. 70R-1494

A synthetic peptide for use as a blocking control in assays to test for specificity of ABHD5 antibody, catalog no. 70R-3842

A synthetic peptide for use as a blocking control in assays to test for specificity of GFRA4 antibody, catalog no. 70R-10339

A synthetic peptide for use as a blocking control in assays to test for specificity of C330003B14RIK antibody, catalog no. 20R-1169

A synthetic peptide for use as a blocking control in assays to test for specificity of TSPAN31 antibody, catalog no. 70R-7187

A synthetic peptide for use as a blocking control in assays to test for specificity of IL22RA1 antibody, catalog no. 70R-6373

A synthetic peptide for use as a blocking control in assays to test for specificity of UXT antibody, catalog no. 70R-1211

A synthetic peptide for use as a blocking control in assays to test for specificity of ZBTB38 antibody, catalog no. 20R-1249

A synthetic peptide for use as a blocking control in assays to test for specificity of IMMP2L antibody, catalog no. 70R-10108

A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797

A synthetic peptide for use as a blocking control in assays to test for specificity of STAT5B antibody, catalog no. 70R-8300

A synthetic peptide for use as a blocking control in assays to test for specificity of VISA antibody, catalog no. 70R-6463

A synthetic peptide for use as a blocking control in assays to test for specificity of PTGER3 antibody, catalog no. 70R-6481

A synthetic peptide for use as a blocking control in assays to test for specificity of RAPGEF1 antibody, catalog no. 70R-5717

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF564 antibody, catalog no. 70R-8115

A synthetic peptide for use as a blocking control in assays to test for specificity of PPM1J antibody, catalog no. 70R-4220

A synthetic peptide for use as a blocking control in assays to test for specificity of CPS1 antibody, catalog no. 70R-1111

Selective blocker of SK2 (KCa2.2) channels

A synthetic peptide for use as a blocking control in assays to test for specificity of CHST13 antibody, catalog no. 70R-7172

A synthetic peptide for use as a blocking control in assays to test for specificity of ABRA antibody, catalog no. 70R-9194

m-dPEG®-Acid (MW = 412) is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. m-dPEG®-Acid (MW = 412) is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of PRDM6 antibody, catalog no. 70R-9062

A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ30934 antibody, catalog no. 70R-9331

AMY1A is a tryptic peptide derived from the alpha-amylase 1 from the salivary gland of the fruit fly, Drosophila melanogaster. Alpha-amylase 1 is a member of the amylase family and has been shown to be biologically active in vitro. AMY1A is used as a calibrator for mass spectrometry and proteomics applications. It is also used in conjunction with other peptides to identify proteins in proteomic experiments.

A synthetic peptide for use as a blocking control in assays to test for specificity of MDP-1 antibody, catalog no. 70R-3521

A synthetic peptide for use as a blocking control in assays to test for specificity of PTGER3 antibody, catalog no. 70R-6938

A synthetic peptide for use as a blocking control in assays to test for specificity of GJD3 antibody, catalog no. 70R-8184

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNRG antibody, catalog no. 70R-5087

A synthetic peptide for use as a blocking control in assays to test for specificity of LYPD6 antibody, catalog no. 70R-5418

A synthetic peptide for use as a blocking control in assays to test for specificity of SLA antibody, catalog no. 70R-2081

A synthetic peptide for use as a blocking control in assays to test for specificity of Loxl2 antibody, catalog no. 70R-9282

A synthetic peptide for use as a blocking control in assays to test for specificity of FBXL2 antibody, catalog no. 70R-3091

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF226 antibody, catalog no. 70R-8219

A synthetic peptide for use as a blocking control in assays to test for specificity of TINAGL1 antibody, catalog no. 70R-4039

A synthetic peptide for use as a blocking control in assays to test for specificity of ZIK1 antibody, catalog no. 20R-1272

Substance P is a neuropeptide that is synthesized from the precursor protein pro-opiomelanocortin (POMC). Substance P has been shown to be a potent inhibitor of the synthesis of proteins that are necessary for cell division. It also stimulates the release of inflammatory mediators and has been shown to have an activator effect on receptors. This product is used as a research tool in cell biology, biochemistry, and pharmacology.

A synthetic peptide for use as a blocking control in assays to test for specificity of RFT1 antibody, catalog no. 70R-5706

A synthetic peptide for use as a blocking control in assays to test for specificity of FEN1 antibody, catalog no. 70R-1605

A synthetic peptide for use as a blocking control in assays to test for specificity of DPH2 antibody, catalog no. 70R-3392

A synthetic peptide for use as a blocking control in assays to test for specificity of FUCA1 antibody, catalog no. 70R-5286

A synthetic peptide for use as a blocking control in assays to test for specificity of GSPT2 antibody, catalog no. 70R-3859

A synthetic peptide for use as a blocking control in assays to test for specificity of ADH4 antibody, catalog no. 70R-2378

Biotin-dPEG®11-Lipoamide is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Biotin-dPEG®11-Lipoamide is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

β-Casomorphin-7 (Bovine) is an opioid peptide that belongs to the class of casomorphins. It is a fragment of the larger ß-casomorphin molecule, which is derived from the breakdown of proline-rich proteins in cow milk. β-Casomorphin-7 has been shown to have potent bronchial and renal proximal effects in rats, as well as analgesic properties. It also inhibits aminopeptidase activity in lung explants and muscle tissues, which may be due to its ability to act on opioid receptors. β-Casomorphin-7 also has been shown to inhibit growth factor production and increase the production of factor β1 in a rat model of pulmonary fibrosis. This may be due to its ability to inhibit inflammation by acting on inflammatory cells such as macrophages or neutrophils.

SARS-CoV-2 Spike RBD 371-394 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 371-394 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 371-394 (Biotin-LC) peptide

A synthetic peptide for use as a blocking control in assays to test for specificity of PCBP4 antibody, catalog no. 70R-1627

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF570 antibody, catalog no. 70R-8409

A synthetic peptide for use as a blocking control in assays to test for specificity of VAMP7 antibody, catalog no. 70R-8715

A synthetic peptide for use as a blocking control in assays to test for specificity of FUT6 antibody, catalog no. 70R-5379

Beta-Casomorphin-7 is a research tool that is used in the study of cell biology and pharmacology. It is an activator of the opioid receptor and a ligand for the receptor. The Beta-Casomorphin-7 (Bovine) antibody can be used to identify receptors on cells involved in protein interactions, ion channels, and high purity. It's CAS number is 72122-62-4.

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNK10 antibody, catalog no. 70R-1533

A synthetic peptide for use as a blocking control in assays to test for specificity of KYNU antibody, catalog no. 70R-1261

Ac-Asp-Asn-Leu-Asp-H (aldehyde) is a peptide that is an agonist of the ion channels. It can be used as a research tool in studies on protein interactions and receptor pharmacology. Ac-Asp-Asn-Leu-Asp-H (aldehyde) binds to the ligand binding site of ion channels, which activates or inhibits their function. This peptide has been shown to inhibit the activity of potassium channels and glutamate receptors, and it can be used as an antibody for cell biology and immunology experiments.

A synthetic peptide for use as a blocking control in assays to test for specificity of CHST7 antibody, catalog no. 70R-1906

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF550 antibody, catalog no. 20R-1242

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF785 antibody, catalog no. 70R-8132

A synthetic peptide for use as a blocking control in assays to test for specificity of Necap1 antibody, catalog no. 70R-9317

A synthetic peptide for use as a blocking control in assays to test for specificity of MBL2 antibody, catalog no. 70R-4596

A synthetic peptide for use as a blocking control in assays to test for specificity of MPV17L antibody, catalog no. 70R-3236

A synthetic peptide for use as a blocking control in assays to test for specificity of UBASH3A antibody, catalog no. 70R-2635

A synthetic peptide for use as a blocking control in assays to test for specificity of TNRC6A antibody, catalog no. 70R-4638

Bis-dPEG®13-NHS Ester is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®13-NHS Ester is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.

A synthetic peptide for use as a blocking control in assays to test for specificity of P2RX2 antibody, catalog no. 70R-1518

A synthetic peptide for use as a blocking control in assays to test for specificity of RAD51L3 antibody, catalog no. 70R-10335

A synthetic peptide for use as a blocking control in assays to test for specificity of CARS antibody, catalog no. 70R-5004

A synthetic peptide for use as a blocking control in assays to test for specificity of WDR23 antibody, catalog no. 70R-3939

A synthetic peptide for use as a blocking control in assays to test for specificity of MFSD1 antibody, catalog no. 70R-6533

Biotin-SARS-CoV-2 Spike RBD 513-520 peptide is the biotinylated version of SARS-CoV-2 Spike RBD 513-520 peptide. SARS-CoV-2 Spike RBD 513-520 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). Biotin-SARS-CoV-2 Spike RBD 513-520 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.

A synthetic peptide for use as a blocking control in assays to test for specificity of C2orf3 antibody, catalog no. 70R-9582

A synthetic peptide for use as a blocking control in assays to test for specificity of LCAT antibody, catalog no. 70R-7207

A synthetic peptide for use as a blocking control in assays to test for specificity of ABCC1 antibody, catalog no. 70R-6981

A synthetic peptide for use as a blocking control in assays to test for specificity of CD44 antibody, catalog no. 70R-10225

A synthetic peptide for use as a blocking control in assays to test for specificity of HP antibody, catalog no. 70R-5419

A synthetic peptide for use as a blocking control in assays to test for specificity of PI16 antibody, catalog no. 70R-6245

Fibronectin is an extracellular matrix protein that plays a critical role in cell adhesion, migration, and differentiation. Fibronectin subunits are composed of repeating units of three types of modules: type I, type II, and type III. The active fragment of fibronectin refers to a small peptide sequence within the type III modules of fibronectin that has been shown to have potent biological activity.
The fibronectin active fragment, also known as the cell-binding domain or RGD domain, is a short peptide sequence consisting of the amino acid sequence Arg-Gly-Asp (RGD). This peptide sequence interacts with cell surface receptors known as integrins, which are important for mediating cell adhesion, migration, and signaling.
The fibronectin active fragment has been extensively studied as a research tool to investigate the mechanisms of cell adhesion and migration. It has also been used in tissue engineering applications to promote cell attachment and proliferation on synthetic biomaterials. This product is available as a 0.5mg vial.

The MYD88 Blocking Peptide is a highly specialized product in the field of Life Sciences, Peptides, and Biochemicals. This peptide plays a crucial role in inhibiting the TGF-beta pathway, which is involved in various cellular processes such as cell growth, differentiation, and apoptosis. By blocking the activity of MYD88, this peptide effectively neutralizes the effects of TGF-beta and prevents abnormal endothelial growth.

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF765 antibody, catalog no. 70R-8901

A synthetic peptide for use as a blocking control in assays to test for specificity of LDHA antibody, catalog no. 70R-3851

A synthetic peptide for use as a blocking control in assays to test for specificity of PGK1 antibody, catalog no. 70R-2755

A synthetic peptide for use as a blocking control in assays to test for specificity of TRPC4AP antibody, catalog no. 70R-5845

A synthetic peptide for use as a blocking control in assays to test for specificity of SPSB2 antibody, catalog no. 70R-10123

A synthetic peptide for use as a blocking control in assays to test for specificity of SCUBE2 antibody, catalog no. 70R-7430

A synthetic peptide for use as a blocking control in assays to test for specificity of UGT3A2 antibody, catalog no. 70R-1871

A synthetic peptide for use as a blocking control in assays to test for specificity of CCDC38 antibody, catalog no. 70R-3282

A synthetic peptide for use as a blocking control in assays to test for specificity of LMAN2 antibody, catalog no. 70R-7315

A synthetic peptide for use as a blocking control in assays to test for specificity of PDIA6 antibody, catalog no. 70R-5434